Ultrasensitive chimerism enhances measurable residual disease testing after allogeneic hematopoietic cell transplantation

Increasing mixed chimerism (reemerging recipient cells) after allogeneic hematopoietic cell transplant (allo-HCT) can indicate relapse, the leading factor determining mortality in blood malignancies. Most clinical chimerism tests have limited sensitivity and are primarily designed to monitor engraft...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanaan, Sami B., Urselli, Francesca, Radich, Jerald P., Nelson, J. Lee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582300/
https://www.ncbi.nlm.nih.gov/pubmed/37467017
http://dx.doi.org/10.1182/bloodadvances.2023010332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582300/
https://www.ncbi.nlm.nih.gov/pubmed/37467017
http://dx.doi.org/10.1182/bloodadvances.2023010332

Ejemplares similares